BioCardia’s novel CardiAMP stem cell therapy closer to approval in heart failure
Focus:
-
![Celltrion]()
Celltrion drug Remsima SC has potential to erode Remicade shares
-
![abicipar pegol]()
Side effect profile of Allergan’s abicipar pegol is a roadblock to penetrating the wAMD Market
-
![iran covid-19]()
Iran, unlike other countries, is experiencing higher fatality during second Covid-19 surge due to healthcare and welfare inequalities
-
![Pregnant women with Covid-19]()
Pregnant women with Covid-19 at greater risk for ICU admission but not mortality
-
![covid-19 vaccine]()
AstraZeneca/Oxford University and CanSino publish promising Covid-19 vaccine clinical trial data, but too early to declare a winner
-
![biosimilar market]()
Educating both payers and patients may hold key to strong and competitive biosimilar market, say experts at BIO Conference 2020
Most Read
Company A-Z
Latest Content
Economic Magnet Seal 2020
In June, Peter Huber Kältemaschinenbau AG from Offenburg was presented with the "Economic Magnet" seal, awarded to organisations who exhibit strong performance in seven indicative areas.
Biopharmaceuticals and Liposomal Formulations
Polymun offers the development of liposomal formulations for all kinds of pharmaceutically active ingredients and vaccine antigens. A broad spectrum of analytical methods has been established for this purpose.
UK teams up with Wockhardt for vaccine manufacturing services
The UK Government has partnered with India-based pharmaceutical company Wockhardt for ‘fill and finish’ services to boost vaccine manufacturing in the UK.
What is the Difference between Translation and Interpreting?
Usually, people who are not a part of the translation industry are not familiar with the differences between translation and interpreting and would need some clarification by a professional before deciding what they do need in terms of linguistic services.
Pfizer and BioNTech to supply 120 million Covid-19 vaccine doses to Japan
Pfizer and BioNTech have entered an agreement with Japan’s Ministry of Health, Labour and Welfare (MHLW) to provide 120 million doses of their BNT162 Covid-19 vaccine candidate.
ISKO Vital™+ Premium Line
During these challenging Covid-19 times, there is a clear emerging need for high-quality, certified face masks that can be manufactured and marketed on a large scale without impacting supplies of Type IIR, FFP2 and FFP3 masks required by medical staff.
Latest News
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.
Close
Close
Close
Go Top